Comparer des méthodes

	Échelle Morisky d'observance médicamenteuse (MMAS)	L'Échelle de fragilité clinique (CFS)
Domaine	Sciences infirmières	Sciences infirmières
Famille	Process / pipeline	Process / pipeline
Année d'origine	1986	2005
Auteur d'origine	Donald E. Morisky	Kenneth Rockwood
Type	Patient self-report questionnaire	Clinician-rated frailty assessment
Source fondatrice	Morisky, D. E., Green, L. W., & Levine, D. M. (1986). Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care, 24(1), 67-74.	Rockwood, K., Song, X., MacKnight, C., et al. (2005). A global clinical measure of fitness and frailty in elderly people. CMAJ, 173(5), 489-495.
Alias	MMAS, Morisky Scale, Medication Adherence Scale	CFS, Frailty Scale, Clinical Frailty Assessment
Apparentées	2	3
Résumé	The Morisky Medication Adherence Scale is a brief, validated tool developed by Donald Morisky in 1986 to measure patients' adherence to prescribed medications. Originally created to assess hypertension medication compliance, it has since become a standard screening instrument across chronic disease management, primary care, and pharmaceutical research. The scale is valued for its brevity, ease of administration, and predictive validity for clinical outcomes.	The Clinical Frailty Scale (CFS), developed by Kenneth Rockwood and colleagues in 2005, is a brief, validated tool for assessing frailty in older adults. Frailty—a syndrome of diminished physiologic reserve, increased vulnerability, and reduced functional ability—is recognized as a distinct clinical state that predicts mortality, disability, and healthcare utilization independent of age and comorbidities. The CFS uses a seven-point (or nine-point in later versions) clinical judgment-based scale, making it practical and rapid for bedside use in hospitals, clinics, and long-term care.